Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000404594

Medchemexpress LLC D(+)-Galactosamine hydrochloride | 1772-03-8 | 99.9% | 215.63 | 500 MG
SDP

Catalog No. 5000404594
Encompass_Preferred

D(+)-Galactosamine hydrochloride is an established experimental toxin that primarily causes liver injury by generating free radicals and depleting UTP nucleotides. It also induces renal dysfunction, with renal failure often associated with the end-stage of liver damage. Lipopolysaccharide/D(+)-Galactosamine-induced acute liver injury is a known animal model of fulminant hepatic failure.

  • Induces apoptosis and necrosis in primary rat hepatocyte cultures.
  • Causes caspase-3 activation and DNA fragmentation.
  • Induces hepatotoxicity similar to viral hepatitis.
  • Suitable for research use only.

Catalog No. 50-004-04594 Supplier Medchemexpress LLC Supplier No. HY42682500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

D(+)-Galactosamine hydrochloride is an established experimental toxin that primarily causes liver injury by generating free radicals and depleting UTP nucleotides. It also induces renal dysfunction, with renal failure often associated with the end-stage of liver damage. Lipopolysaccharide/D(+)-Galactosamine-induced acute liver injury is a known animal model of fulminant hepatic failure.

  • Induces apoptosis and necrosis in primary rat hepatocyte cultures.
  • Causes caspase-3 activation and DNA fragmentation.
  • Induces hepatotoxicity similar to viral hepatitis.
  • Suitable for research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.